BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12843056)

  • 1. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.
    Newman FK; Frey SE; Blevins TP; Mandava M; Bonifacio A; Yan L; Belshe RB
    J Clin Microbiol; 2003 Jul; 41(7):3154-7. PubMed ID: 12843056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent neutralizing-antibody responses to vaccinia.
    Belshe RB; Newman FK; Frey SE; Couch RB; Treanor JJ; Tacket CO; Yan L
    J Infect Dis; 2004 Feb; 189(3):493-7. PubMed ID: 14745707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.
    Hsieh SM; Chen SY; Sheu GC; Hung MN; Chou WH; Chang SC; Hsu KH
    Vaccine; 2006 Jan; 24(4):510-5. PubMed ID: 16139395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.
    Viner KM; Isaacs SN
    Microbes Infect; 2005 Apr; 7(4):579-83. PubMed ID: 15848274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.
    Liu Q; Huang W; Nie J; Zhu R; Gao D; Song A; Meng S; Xu X; Wang Y
    PLoS One; 2012; 7(3):e33392. PubMed ID: 22438922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
    Kennedy JS; Gurwith M; Dekker CL; Frey SE; Edwards KM; Kenner J; Lock M; Empig C; Morikawa S; Saijo M; Yokote H; Karem K; Damon I; Perlroth M; Greenberg RN
    J Infect Dis; 2011 Nov; 204(9):1395-402. PubMed ID: 21921208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations.
    Slike BM; Creegan M; Marovich M; Ngauy V
    PLoS One; 2017; 12(1):e0169247. PubMed ID: 28046039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to smallpox vaccine in persons immunized in the distant past.
    Frey SE; Newman FK; Yan L; Lottenbach KR; Belshe RB
    JAMA; 2003 Jun; 289(24):3295-9. PubMed ID: 12824212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naïve individuals is related to differences in antibody profiles before vaccination, not after.
    Tan X; Chun S; Pablo J; Felgner P; Liang X; Davies DH
    Clin Vaccine Immunol; 2012 Mar; 19(3):418-28. PubMed ID: 22258709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.
    Kim SH; Yeo SG; Jang HC; Park WB; Lee CS; Lee KD; Kim HB; Kim NJ; Kim YT; Jee Y; Cho H; Oh MD; Choe KW
    J Infect Dis; 2005 Sep; 192(6):1066-70. PubMed ID: 16107961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial.
    Jackson LA; Frey SE; El Sahly HM; Mulligan MJ; Winokur PL; Kotloff KL; Campbell JD; Atmar RL; Graham I; Anderson EJ; Anderson EL; Patel SM; Fields C; Keitel W; Rouphael N; Hill H; Goll JB
    Vaccine; 2017 Mar; 35(13):1675-1682. PubMed ID: 28256358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of human immunological responses to vaccinia virus.
    Harrop R; Ryan MG; Golding H; Redchenko I; Carroll MW
    Methods Mol Biol; 2004; 269():243-66. PubMed ID: 15114020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
    Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
    Hughes CM; Newman FK; Davidson WB; Olson VA; Smith SK; Holman RC; Yan L; Frey SE; Belshe RB; Karem KL; Damon IK
    Clin Vaccine Immunol; 2012 Jul; 19(7):1116-8. PubMed ID: 22593237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.
    Parrino J; McCurdy LH; Larkin BD; Gordon IJ; Rucker SE; Enama ME; Koup RA; Roederer M; Bailer RT; Moodie Z; Gu L; Yan L; Graham BS;
    Vaccine; 2007 Feb; 25(8):1513-25. PubMed ID: 17126963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
    Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
    Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
    Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
    J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.
    Perera LP; Waldmann TA; Mosca JD; Baldwin N; Berzofsky JA; Oh S
    J Virol; 2007 Aug; 81(16):8774-83. PubMed ID: 17553867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.